- Title: Subtitle
- Nebulizer use in tobacco-exposed SPIROMICS participants with or at risk of COPD
- Creators
- J Fazio - University of California, Los AngelesA Hong - University of California, Los AngelesD MarkovicR G Barr - Columbia UniversityE Bleecker - University of ArizonaR P Bowler - National Jewish HealthD Couper - University of North Carolina at Chapel HillJ L Curtis - University of Michigan–Ann ArborB Drummond - University of North Carolina at Chapel HillS Fortis - University of IowaM Han - University of Michigan–Ann ArborL Holland - University of North Carolina at Chapel HillV Kim - Temple UniversityF J Martinez - Cornell UniversityJ Ohar - Wake Forest UniversityV E Ortega - Mayo Clinic in ArizonaR Paine - University of UtahM Wells - University of Alabama at BirminghamP Woodruff - University of California, San FranciscoR Buhr - University of California, Los AngelesC B Cooper - University of California, Los AngelesD Tashkin - University of California, Los AngelesI Barjaktarevic - University of California, Los Angeles
- Resource Type
- Abstract
- Publication Details
- European respiratory journal, Vol.60(Suppl. 66), p.2452
- Publisher
- European Respiratory Society
- DOI
- 10.1183/13993003.congress-2022.2452
- ISSN
- 0903-1936
- eISSN
- 1399-3003
- Language
- English
- Date published
- 09/04/2022
- Academic Unit
- Internal Medicine; Pulmonary, Critical Care, and Occupational Medicine
- Record Identifier
- 9984532188902771
Abstract
Nebulizer use in tobacco-exposed SPIROMICS participants with or at risk of COPD
European respiratory journal, Vol.60(Suppl. 66), p.2452
09/04/2022
DOI: 10.1183/13993003.congress-2022.2452
Details
Metrics
4 Record Views